Macro environment determinants affecting the availability of artemisinin-based combination therapies in Uganda

被引:0
|
作者
Oluka Nagitta, Pross [1 ]
Mkansi, Marcia [2 ]
机构
[1] Uganda Management Inst, Dept Econ & Managerial Sci, Kampala, Uganda
[2] Univ South Africa, Dept Operat Management, Pretoria, South Africa
关键词
Pharmaceutical supply chain; Political factors; Economic; Social-cultural; Legal; Technology; Developing countries; DEVELOPING-COUNTRIES; MALARIA; HEALTH; PROCUREMENT; MANAGEMENT; MEDICINE;
D O I
10.1108/IJPHM-09-2020-0074
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
PurposeArtemisinin-based combination therapies (ACTs) have been developed to treat uncomplicated malaria. However, scanty studies exist to inform the role of macro factors in explaining the nonavailability of ACT in developing countries. Therefore, this paper aims to evaluate the different macro-environment factors affecting the availability of ACTs in the public hospital setting. Design/methodology/approachThis study applied a quantitative methodological approach and structural equation modeling (SEM) to test hypotheses statistically. SEM examines linear causal relationships among variables while accounting for measurement error. Confirmatory factor analysis (CFA) was used to assess model reliability. CFA and SEM were used to determine the shared variance-covariance of variables, define the latent construct and provide a more precise way to account for the error variances associated with the variables, which, if untested, could lead to biased parameter estimates. This was guided by the data collected from 40 general public hospitals with 283 respondents. FindingsThis study's results support a model for promoting social-cultural, technological and legal factors. The availability of ACTs is significantly affected by legal factors. Improving legal aspects by a unit can enhance ACT availability by 0.59. Political factors scored the least, and they do not influence the availability of malaria drugs. Research limitations/implicationsThe design was quantitative and cross-sectional. Future research could be longitudinal with a mixed-method approach and consider other external stakeholders. Practical implicationsReducing the impact of the nonavailability of antimalarial drugs in general public hospitals requires a holistic concerted and coordinated supply chain approach that tackles the political, economic, social-cultural norms, technological and legal factors. Originality/valueThe authors develop and test a model using macro factors: political, economic, social, cultural, technological and legal factors. This model is relevant for many developing countries to supply chain coordination perpetually experiencing medicine shortages.
引用
收藏
页码:97 / 114
页数:18
相关论文
共 50 条
  • [21] Artemisinin-based combination therapies: a vital tool in efforts to eliminate malaria
    Richard T. Eastman
    David A. Fidock
    Nature Reviews Microbiology, 2009, 7 : 864 - 874
  • [22] Preventing antimalarial drug resistance with triple artemisinin-based combination therapies
    Nguyen, Tran Dang
    Gao, Bo
    Amaratunga, Chanaki
    Dhorda, Mehul
    Tran, Thu Nguyen-Anh
    White, Nicholas J.
    Dondorp, Arjen M.
    Boni, Maciej F.
    Aguas, Ricardo
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [23] Predicting Global Fund grant disbursements artemisinin-based combination therapies
    Cohen, Justin M.
    Singh, Inder
    O'Brien, Megan E.
    MALARIA JOURNAL, 2008, 7 (1)
  • [24] "Misstatements in Artemisinin-Based Combination Therapies in Malaria Treatment" by Fleckenstein and Miller
    Maldonado, Joyce Hernandez
    Grundmann, Oliver
    JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 62 (10): : 1323 - 1324
  • [25] Preventing antimalarial drug resistance with triple artemisinin-based combination therapies
    Tran Dang Nguyen
    Bo Gao
    Chanaki Amaratunga
    Mehul Dhorda
    Thu Nguyen-Anh Tran
    Nicholas J. White
    Arjen M. Dondorp
    Maciej F. Boni
    Ricardo Aguas
    Nature Communications, 14
  • [26] Efficacy of non-artemisinin- and artemisinin-based combination therapies for uncomplicated falciparum malaria in Cameroon
    Solange Youdom Whegang
    Rachida Tahar
    Vincent Ngane Foumane
    Georges Soula
    Henri Gwét
    Jean-Christophe Thalabard
    Leonardo K Basco
    Malaria Journal, 9
  • [27] Efficacy of non-artemisinin- and artemisinin-based combination therapies for uncomplicated falciparum malaria in Cameroon
    Whegang, Solange Youdom
    Tahar, Rachida
    Foumane, Vincent Ngane
    Soula, Georges
    Gwet, Henri
    Thalabard, Jean-Christophe
    Basco, Leonardo K.
    MALARIA JOURNAL, 2010, 9
  • [28] Artemisinin resistance or artemisinin-based combination therapy resistance?
    Wongsrichanalai, Chansuda
    LANCET INFECTIOUS DISEASES, 2013, 13 (02): : 114 - 115
  • [29] Safety of Artemisinin-Based Combination Therapies in Nigeria: A Cohort Event Monitoring Study
    Peter Usman Bassi
    Adeline I. Osakwe
    Ambrose Isah
    Comfort Suku
    Musa Kalat
    Iliya Jalo
    Robinson Daniel Wammanda
    Chika Ugochukwu
    Olubukula Adesina
    Eno Etim Nyong
    Frank Osungwu
    Shanti Pal
    Sylvester Chigozie Nwoasu
    Magnus Wallberg
    David Coulter
    Drug Safety, 2013, 36 : 747 - 756
  • [30] A major transition in malaria treatment: The adoption and deployment of artemisinin-based combination therapies
    Bosman, Andrea
    Mendis, Kamini N.
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2007, 77 (06): : 193 - 197